Fig. 4From: Development and validation of a radiopathomic model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer patientsFeature selection process. Radiomics features (A, B) and pathomics features (C, D) were selected by the LASSO model with tuning parameter (λ) using fivefold cross-validation via minimum and 1se criteriaBack to article page